Recent research has reported that multiple stakeholders are impacted by the availability and accessibility of treatments for Multiple Sclerosis in the United States. Understanding that Value goes beyond the cost of the treatment, we want to hear from YOU about:
- Which stakeholders/groups are important when discussing the availability and accessibility of MS therapies
- Stakeholders/groups level of influence on decision making for the availability and accessibility of MS therapies
- Data and/or information the stakeholders/groups need to make their decisions
Please take this 5-minute survey, and 4 individuals who complete the survey will be randomly selected to win a $25.00 gift card from Amazon.Com.